DEF 14AThe Ballot
Seres Therapeutics, Inc. files DEF 14A
Filed Mar 5, 2024 · 2y ago · Accession 0000950170-24-025482
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Seres Therapeutics, Inc.
- Ticker
- MCRB
- CIK
- 1609809
- Form type
- DEF 14A
- Filing date
- Mar 5, 2024
- Report date
- Mar 5, 2024
- Document
- mcrb-20240305.htm
- Size
- 4.8 MB